Novoa VA, Grados GC, Bustillos DR , Malagón MB

Language: Spanish
References: 24
Page: 666-673
PDF size: 104.06 Kb.

ABSTRACT

Pregnancy complicated with gallbladder disease stone has an incidence of 2-14%, and more than 30% of patients do not respond to medical treatment; therefore, in order to reduce the morbidity and mortality in fetus and mother, surgical management would be required. The current use of ultrasound of high resolution has facilitated the diagnosis and also, in the present clinical case, this imaging modality allowed us to suspect the unusual diagnosis reported, that corresponds to a female of 34 years old with 33 weeks of pregnancy, complicated with symptomatic gallbladder disease stone, whose pain was intractable at the expectant management. The clinical diagnosis was corroborated by ultrasound and the report was: lithiasis, biliary sludge and an intragallbladder image of bilobular polypoid. The patient was submitted to cholecystectomy by laparotomy, whose histopathologic findings were: cholelithiasis and in situ gallbladder adenocarcinoma with an exophytic growing variety. The purposes of this article are to report a case and to review the literature.

REFERENCES

1. DeVita VT, Hellman S, Rosenberg SA. Cancer. Principles and practice of oncology. 6th ed. Lippincott Williams and Wilkins, 2001;pp:1550-6.

2. Trimble EL. A guest editorial: update on diethylstilbestrol. Obstet Gynecol Surv 2001;56(4):187-9.

3. Kirkbride P, Fyles A, Rawlings GA, Anchul Lewin W, Murphy KC, Simm J. Carcinoma of the vagina, experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol 1995;56:435-43.

4. Steed HL, Pearcey RG, Capstick V, Honore LH. Invasive squamous cell carcinoma of the vagina during pregnancy. Obstet Gynecol 2002;100(5 Pt2):1105-8.

5. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.

6. William H. Natcher Center. Featured report. DES research update 1999: current knowledge, future directions. Bethesda: National Institutes of Health (NIH), 1999;pp:19-20.

7. Faber K, Jones M, Terraza MH Jr. Invasive squamous cell carcinoma of the vagina in a diethylstilbestrol-exposed woman. Gynecol Oncol 1990;37:125-8.

8. Waggoner ES, Mittendorf R, Biney N, Herbest LA. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vagina clear-cell adenocarcinoma. Gynecol Oncol 1994;55:238-44.

9. Sistema Nacional de Salud. Boletín de información y estadística, daños a la salud, 1998;18(2):338.

10. Sistema Nacional de Salud. Anuario estadístico de los servicios de salud y los servicios de salud de los estados, 1999;pp:113.

11. Schrager S, Potter EB. Diethylstilbestrol exposure. Am Fam Physician 2004;69(10):2395-400.

12. Herbst AL, Scully ER. Adenocarcinoma of the vagina in adolescence. Cancer 1970;25:745-57.

13. Kruse N, Lauver D, Hanson K. Clinical implications of DES. Nurse Pract 2003;28(7):26-35.

14. Hammes B, Laitman CJ. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals. J Midwifery Womens Health 2003;48(1):19-29.

15. BC Cancer Agency. Care and research. Diethylstilbestrol. http://www.bccancer.beca/HPI/DrugIndexPro/Diethylstilbestrol.htm

16. Philip R, Williams PJ. Oncología clínica. 8a ed. Elsevier Science, 2003;pp:499-503.

17. González-Merlo J. Oncología ginecológica. Salvat Editores, 1991;pp:605-803.

18. Scully RE, Welch WR. Pathology of the female genital tract after prenatal exposure to dietihylstilbestrol. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme Stratton, 1981;p:26.

19. Mock U, Kucera H, Fellner C, Hendrik KT, Potter R. High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys 2003;56(4):950-7.

20. Griffiths MJ, Murray KH, Phyllis RC. Oncología básica, fisiopatología, evaluación y tratamiento. La Prensa Médica Mexicana, 1998;pp:451-5.

21. Senekjian E, Frey K, Anderson D, et al. Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer 1987;60:1319.

22. Senekjian E, Frey K, Stone C, et al. An evaluation of stage II vaginal clear cell adenocarcinoma according to sub stage. Gynecol Oncol 1988;31:56.

23. Pérez CA, Brady Luther W. Principles and practice of radiation oncology. 2nd ed. JB Lippincott Co, 1992;pp:1258-72.

24. Thigpen T, Blessing J, Homesley HD, et al. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina. Cancer Treat Rep 1987;71:869.